Odyssean »

Bridgebio Pharma shares owned by Odyssean

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Odyssean from 13F filings

Historical chart of Odyssean investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Odyssean consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Odyssean

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.1M 41k 74.48

More positions owned by Odyssean

Ultragenyx Pharmaceutical (RARE)
Kymera Therapeutics (KYMR)
Ideaya Biosciences (IDYA)
Vaxcyte (PCVX)
Affirm Hldgs Com Cl A (AFRM)
Celldex Therapeutics Com New (CLDX)
Loar Holdings Com Shs (LOAR)
Mirum Pharmaceuticals (MIRM)
Doordash Cl A (DASH)
Krystal Biotech (KRYS)
Viking Holdings Ord Shs (VIK)
Medpace Hldgs (MEDP)
Toast Cl A (TOST)
American Healthcare Reit Com Shs (AHR)
Nicolet Bankshares (NIC)

View all positions for Odyssean

Top funds holding Bridgebio Pharma

BlackRock
Jupiter Topco
Kohlberg Kravis Roberts & Co
Henderson Group
Viking Global Investors
Farallon Capital Management
Vanguard Capital Management
Vanguard Portfolio Management
Jane Street
UBS Group
Aisling Capital Management
State Street Corporation
Geode Capital Management
Citadel Advisors
T. Rowe Price Associates

View all funds holding Bridgebio Pharma